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ABSTRACT
Pulsatile ultradian secretion of cortisol, rarely studied in salivary data, has functional 
importance in hypothalamic pituitary adrenal (HPA) axis regulation. The first daily ultradian 
episode, the cortisol awakening response (CAR), was examined in healthy adults, in 5-min 
secretion rates of salivary cortisol from electronically monitored awakening time to 1.25h. 
Aggregated rates revealed a cubic trend, with wave-length of almost exactly 1h, as predicted 
from known ultradian periodicity. Peak secretion rate occurred 20-min post-awakening. Peak 
(20-min) to trough (59-min) amplitude (PTA) expressed a salient signal shape. Rates rose 
steeply to and from peak, and major secretion was packaged into a few 5-min intervals, 
inconsistent with normal or uniform distribution of 5-min rates, but consistent with known 
pulsatile cortisol delivery. Null hypotheses asserting normal or uniform distributions were 
rejected. Maximal rates overwhelmingly occurred before and minimal rates after 30-mins, 
with degree of extremity at each polarity significantly positively correlated.
To demonstrate utility and reliability of PTA estimation in a clinically relevant domain, re- 
analyses of a previously published study were conducted. Data from only three saliva 
samples were used, given importance of cost considerations for many CAR researchers. 
Difference between mean rates before and after 30-min yielded a simple salience index, 
highly correlated with PTA derived from full 5-min interval data. CAR salience performed 
significantly better than traditional AUCi magnitude in discriminating control cases (higher 
inferred amplitude) and cases with Seasonal Affective Disorder (lower inferred amplitude). 
Evidence suggested that low AUCi may be more sensitive in identifying within-subject 
changes (e.g. more depressed mood in winter among SAD cases) and low CAR salience 
better at revealing enduring between-subjects associations (e.g. underlying disorder 
vulnerability). Since both PTA salience and AUCi magnitude can be analysed and compared 
using exactly the same data from the same commonly used saliva sampling points, further 
research is warranted into the importance of individual differences in patterns of cortisol 
delivery, not just how much is delivered.
1. Introduction
The cortisol awakening response (CAR) is extensively studied for associations with health 
and illness (Desantis et al., 2015; Gardner et al., 2013; Kudielka and Kirschbaum, 2003; 
O'Connor et al., 2009) and cognitive function (Law et al., 2015; Pruessner et al., 2007; 
Rimmele et al., 2010; Shi et al., 2018). The literature reveals much inconsistency, and poor 
accuracy, in estimating sampling times from awakening, is probably a factor (Broderick et al., 
2004; Dockray et al., 2008; Kudielka et al., 2003; Smyth et al., 2016; Stalder et al., 2016). 
However, other factors may exist. Aspects of the CAR, ignored by conventional measures, 
might be more strongly linked to commonly studied variables in PNEC research. Specifically, 
we ask whether traditional measures over-emphasize cumulative total of cortisol delivered, 
and under-estimate secretory process.
Conventionally, the CAR is calculated as area under the curve of cortisol increase (AUCi) 
from awakening, or its near equivalent of mean increase (MnInc) from awakening. All 
increases, regardless of size and location in the post-awakening period, contribute to AUCi. 
Yet secretion occurs in large ultradian bursts, at roughly hourly intervals, with little activity 
between them. Pulsatile delivery is necessary for efficient HPA axis signalling (Flynn et al., 
2018; Lightman and Conway-Campbell, 2010). The possible functional significance of CAR 
secretion ‘shapes’, as salient signals reflecting the pulsatile nature of secretion, has largely 
prompted these investigations Typically, pulsatility is studied using continuous blood 
sampling. Sparse saliva sampling in humans provides a less vivid picture.  At most times, 
individual bursts tend to be lost in an averaging process. An exception is the hour after 
awakening. The CAR, the first and largest ultradian episode of the day, is detectable in 
aggregated data since all participants’ CARs are synchronised to awakening time (Clow et 
al., 2010)  with concentrations peaking around 30-min afterwards (Clow et al., 2004; 
Kudielka and Kirschbaum, 2003; Pruessner et al., 1997). But this is approximate. AUCi 
measures do not locate brief activity bursts, although these probably account for most of an 
individual’s CAR. AUCi measures do not discriminate between two individuals, with identical 
amounts of cortisol, one delivered in a massive brief response, the other in a series of much 
smaller rises over a longer time. 
Pulsatility entails brief and rapid changes in secretion rates, with steep rate falls as well as 
rate rises. This was first observed in rodent blood samples (Lightman and Conway-
Campbell, 2010; Veldhuis et al., 1989) and more recently has been revealed by 
deconvolution analysis in saliva samples (Trifonova et al., 2013). We can imagine a 
hypothetical case of all significant rise delivered in a few early bursts, followed swiftly by all 
significant fall. An overall shape would emerge with steep rise in rate, clear rate peak, and 
steep rate fall, exhibiting a quality we shall refer to as response salience, literally the 
response ‘jumping’ out from background. The CAR, as an ultradian as well as a diurnal 
event, forms part of a secretory cycle, with a wave form consisting of a peak and trough in 
secretory activity. Peak to trough wave amplitude (PTA) is a simple and standard measure of 
signal salience in any field of study, which deals in waves. We hypothesise that higher wave 
amplitude may indicate potentially clearer feedback signalling within the HPA axis.
Unlike CAR concentration, the higher order curve of changing net secretion rates has 
received scant attention. Locating bursts of secretory activity requires almost continuous 
sampling. By contrast sparse sampling protocols are required in most CAR research if large 
sample studies are to be economically viable. Using a unique data-set of almost continuous 
saliva sampling at 5-min intervals from electronically monitored time of awakening (Smyth et 
al., 2013; Smyth et al., 2015), we have been able to remedy this gap in our knowledge. 
Over a time exceeding one hour, we expected to find a wave-length of approximately one 
hour, confirming known average ultradian period length. We expected individuals’ total rise 
and fall would be packaged into just a few intervals of extremely high positive and extremely 
low negative rates at either end of a 5-min secretion rate leptokurtic distribution. Two null 
hypotheses were formulated: (1) that secretion rate would be distributed normally around 
individual means, and (2) that they would follow a uniform (rectangular) platykurtic 
distribution with near constant rate of delivery across samples. Individuals’ maximum 5-min 
secretion rates were expected to be located largely before 30-mins and be positive (i.e. 
rises) and minimum rates after 30-mins and be negative (i.e. falls). Maximum rise and fall 
rates would be positively correlated, supporting a construct of response amplitude potency 
within a secretory cycle. Differences between maximum and minimum 5-min secretion rate 
before and after 30-mins, respectively, should provide approximate individual estimates of 
PTA, with bigger amplitude implying a stronger and more salient signal. 
Finally, we sought to demonstrate utility of a derived very simple salience measure in a 
much sparser but frequently used 45-mins sampling regime, comparing its performance with 
that of AUCi, in a re-analysis of a published clinical study of Seasonal Affective Disorder 
(Thorn et al., 2011). Its composition of SAD and control cases, made it ideal to compare 
discriminative potential of both measures. Four repeated measures (two days in both 
summer and winter) permitted comparison also of temporal stability.
2. Methods
2.1. Study 1: 5-min saliva database and procedure
The database of individual time series followed a protocol of cortisol sampling at 5-min 
intervals from awakening up to 60-mins later and originated from two previously published 
studies by our group: Smyth et al. (2013) and (Smyth et al., 2015). Cases comprised a total 
of 56 participant days, with 25 participants providing two consecutive days of data and 6 
participants providing only a single day’s data. Participants were recruited from the academic 
community at the University of Westminster (median age 20 years and inter-quartile range 
18–22 years). The samples comprised approximately equal numbers of males (N = 16) and 
females (N=15). All were non-smokers, and none were suffering from any medical or 
psychiatric illness, or taking any steroid-based medication.
The protocol was similar in both studies. In Smyth et al. (2013 participants were required to 
collect saliva samples in domestic setting immediately on awakening and at 5-min until 45-
mins post-awakening and then a sample at 60-mins post-awakening (11 samples), whereas 
in Smyth et al. (2015) samples were collected every 5-min for the full 60-mins post 
awakening period (13 samples). In both studies, participants were asked if possible to collect 
samples on two days. Participants attended an individual induction session, during which 
they were given full verbal and written instructions on saliva sampling and electronic-
monitoring procedures, and were given the opportunity to practise collecting saliva samples 
using salivette devices (Sarstedt Ltd., Leicester, England). Participants were asked to wake 
up in their habitual manner and to resist from smoking, brushing their teeth and exercising, 
and to remain nil by mouth bar water during the saliva collection period. Participants 
completed record sheets on each day, which included information regarding their awakening 
times, their protocol-required saliva sampling times based on their awakening time that day, 
and their actual saliva sampling times. In all studies participants were informed about the 
need to follow the strict sampling regime and were informed that the electronic devices 
would be used to verify their self-reported awakening and saliva sampling times, as this has 
been shown to increase sampling accuracy (Broderick et al., 2004; Kudielka et al., 2003). 
Time of awakening and collection of the first sample were verified by electronic devices 
(actiwatch and MEMs respectively). Given the verified timings of samples, it was possible in 
the first analysis of overall 5-min secretion rate trend to include all samples using their real 
timing (see Smyth et al. 2016), including a minority which, in terms of protocol instructions, 
were delayed by up to 15-min (Md = 10-min). This meant that accurately timed samples 
covered a post-awakening period of up to 1.25h in the first analysis. In all subsequent 
analyses, where the CAR was studied over a more traditional 45-min post-awakening period, 
all cases (N=42) were required to have minimal delay for the awakening sample (Md = 2-
min) and full data for each 5-min interval thereafter to 45-min post-awakening. For an 
overview of the protocol see the source publications (Smyth et al., 2013; Smyth et al., 
2015;). Participants were asked to store their samples in a domestic freezer, and on return to 
the laboratory, they were stored at −20 °C until assayed.
2.2. Study 2: Seasonal Affective Disorder (SAD) database and procedure
The database used for the final analyses contained cortisol data from community samples of 
26 self-assessed SAD participants and 26 age- and sex-matched control participants (Thorn 
et al., 2011). All were healthy i.e. no medication, no chronic illness, no history of psychiatric 
illness (other than SAD), no eating or sleep disorder. SAD participants reached the criteria 
for SAD as assessed by Seasonal Pattern Assessment Questionnaire (SPAQ, Rosenthal et 
al., 1987). All participants were white European, there were 34 females and 18 males, age 
ranging between 26 and 75 years with a mean (+SD) age of 50 (+12) years.
Participants were required to collect saliva samples, in their domestic setting, immediately on 
awakening, then at 15-, 30-, 45-mins post-awakening on two successive days in winter 
(November/December) and summer (June/July), with order of season being 
counterbalanced between participants. The saliva sampling research induction, the protocol 
for self-collecting and return of saliva samples was the same as study 1 with the added 
instructions to refrain from using light therapy on the winter study days.
2.3. Cortisol Determination
In both studies cortisol concentrations were determined by enzyme linked immunosorbent 
assay developed by Salimetrics LLC (USA) at the Psychophysiology and Stress Research 
Group’s laboratory at the University of Westminster. Standards, controls and all samples 
were assayed in duplicate and intra and inter-assay variations were both below 10%.
2.4. Treatment of data and statistical analyses
2.4.1. 5-min data-set
For the purpose of inferential parametric analyses, cortisol secretion rates (nmols/l/5-min) 
and concentrations (nmols/l) were first examined for outliers and winsorized to +/- 3sd.  
Concentrations were positively skewed and root transformed to yield a distribution with a 
reduced skewness statistic, fulfilling or approximating, as closely as possible to, the ideal of 
not being greater than twice its standard error. Descriptives and plotted data are presented 
in original units of measurement. In the first analysis of secretion rate trend from 0–1.25h 
post-awakening, multi-level polynomial modelling is undertaken up to the cubic term, with 
correlated random effects specified for participants. Correlated residuals within random 
effects from repeated sampling over days are modelled using simple (AR1) autoregression.
 In the second series of analyses, where non-normal distributional characteristics are 
themselves the point of enquiry, descriptives of central tendency and dispersion are 
presented as medians and inter-quartile ranges. Null hypotheses of normal and uniform 
distribution are tested by the non-parametric one sample Kolmogorov-Smirnoff test. Simple 
zero-order correlations are throughout reported as Spearman’s rho (rs). 
In the third series of analyses, individuals’ minimum 5-min secretion rates after 30 mins were 
subtracted from their maximum 5-min secretion rates before 30 mins, using all data from the 
entire post-awakening period in one analysis and a shorter 45-min period used in typical 
sparsely sampled CAR protocols in a further analysis.  The former provides a direct 
‘salience’ measure of individual contributions to the aggregated PTA calculated from the 
cubic curve derived in the polynomial analysis described earlier. The latter estimates 
individual contributions to a proxy measure of PTA in the form of response amplitude and 
salience for the shorter 45-min period, which was expected to correlate highly with PTA over 
the entire cycle.  
2.4.2. SAD data-set
Typical large sample CAR studies require minimal saliva collection and assay costs in order 
to be economically viable. Therefore, to maximise demonstration of utility of a simple 
measure of CAR salience, the sparsest possible sampling regime was assumed. PTA 
estimates were calculated from just three of four samples collected in the original study: at 
awakening (s0), at 30-mins (s30) and at 45-mins (s45). A simple salience score was 
calculated as the difference between an individual’s mean secretion rate before 30-mins and 
after 30-mins, (see Box 1 for formulaic expression and illustrative figure). Since component 
intervals had different durations, rates are expressed against a common time unit 
(nmols/l/min). Such sparse sampling cannot locate individual secretion rate peaks but 
assumes them to be largely prior to 30-mins, as of course does the simple and much used 
s30-s0 traditional CAR measure. Prior to presenting SAD analyses,  assumptions underlying 
the rationale of this proposed simple salience measure were tested in the 5-min data-set and 
correlations reported between it and PTA estimates based on real 5-min maxima and 
minima of secretory activity. 
In SAD study data, simple salience scores were positively skewed, and so root transformed 
to bring skewness to within the acceptable range. Applying the formula to already root 
transformed component measures and back transforming produced near identical analyses. 
In the interests of  instructional simplicity we have presented the formula for salience in Box 
1 in terms of raw cortisol values. We caution that such salience scores should be expected 
to contain outliers and  be positively skewed, and should be transformed accordingly before 
being used in parametric inferential analyses. 
After first averaging measures from all four occasions to express a trait-like variable, binary 
logistic regression was used to assess how well simple salience discriminated between SAD 
cases and control cases, and to compare performance with a traditional AUCi measure of 
total cortisol secretion over awakening base. Significance and effect size are reported as 
Wald statistic and Nagelkerke’s pseudo-R2, respectively. Like the more familiar genuine R2 
from OLS regression analyses, Nagalkerke values are constructed to vary between 0 and 1, 
and provide a similar idea of how much a variable contributes over and above the intercept 
only model. To examine seasonal variation in CAR magnitude and CAR salience, alongside 
that of SAD status, dependent and independent variables were reversed and mixed 
regression multi-level modelling was used. For these models, df = 1 for each repeated 
measure, and compound symmetry, equivalent to random intercept model, was assumed for 
correlated residuals.
A primary concern of CAR researchers will always be to minimize as far as possible saliva 
collection and assaying costs. Subsidiary analyses are not therefore presented which 
included data from a fourth additional 15-min sample collected in the original study 2. These 
analyses did not suggest any significantly better performance over findings reported here for 
3 sample measures of CAR salience and magnitude.
3. Results
3.1. Study 1: Trend of 5-min net secretions rates for aggregated data
Figure 1 shows the predicted S-shaped trend in net secretion rates across 5-min intervals 
from awakening to 75-mins thereafter (Fcubic = 14.47; df = 1,440; p<.001). The assumption 
that the CAR represents the first ultradian secretory episode of the day, was supported, with 
a predicted average low point to low point inter-period interval (IPI) length of almost exactly 
one hour (59-mins). This figure was accurately mirrored by averages to nearest minute of 
individual cases’ post-peak minima, giving a mean of 58 +/-3 min (95% CI), and a median of 
61 +/- 4 min (IQR). Peak to trough amplitude of the wave function represented a secretion 
rate difference of 2.52 nmols/l/5-min. Rates accelerated from negativity at awakening to 
peak at 1.62 nmols/l/5-min at 21-mins, turned negative again (-0.90 nmol/l/5-min) around the 
hour point nadir, before rising once more. Finally a similar analysis of the same data 
expressed as a cortisol concentration growth curve was undertaken to derive a quadratic 
equation from which we could calculate an estimate of cortisol half-life from peak (T1/2). An 
estimate of 40-min was determined.
Figure 1. Cubic trend of mean secretion rate showing the peak to-trough amplitude 
(PTA) and period wave length of 59-min
3.2. Study 1: Evidence of episodic nature of individual secretory activity from awakening to 
45-min.
Since the distribution of 5-min interval secretion rates was hypothesised to be leptokurtic, 
non-parametric (distribution-free) descriptive statistics (median and IQR) are presented in 
Table 1. Maximum and second highest rates averaged 4.55 and 3.45 nmols/l/5-min 
respectively. Equivalent minimal rates were -3.43 and -1.41, the negative signs indicating 
fall. The median rate for all other sample intervals was 1.21. The degree of difference is put 
into perspective by calculating the contribution of maximal and minimal samples to total rise 
and fall respectively. Cases typically had six out of a possible nine 5-min intervals which 
showed rises. Individuals’ single maximum sample delivered on average over a third (37%) 
of total rise. Combining first and second highest rates given in Table 1, these two samples, 
constituting one third of all rise intervals, accounted for 62% of all rise. The statistics for fall 
(negative rates) show the same disproportionality of contribution. Cases on average 
registered three falls. Individuals’ single minimum rates were all falls and accounted for 60% 
of total.
Table 1. Non-parametric descriptive and inferential statistics indicative of 
underlying episodic pulsatility in the pattern of cortisol delivery. 
5-min Interval 
Secretion Rates
Interval Rate          
nmols/l/5min                   
Md (IQR)
Contribution of 
one 5-min 
interval to total 
rise or fall 
(Percentage)
Location (min)        
from wake time 
Md (IQR)
Highest 
secretion rate 
(42 cases)
4.55 (3.04) 37 25 (10)
2nd Highest rise 
rate (42 cases)
3.45 (2.33) 25 20 (10)
Lowest 
secretion rate 
(42 cases)
-3.43 (2.49) 60 30 (26)
2ndLowest 
secretion rate 
(42 cases)
-1.41 (1.79) 27 35 (16)
Average of 
other rates (210 
cases)
1.21 (2.56)
Inferential 
Tests
All secretion 
rates
(N =378 cases)
Correlation 
between max & 
min rates
K-S Test (H0 = 
Normal)
Test Stat = .08; 
p<.001
K-S Test (H0 = 
Uniform)
Z= 6.98; p<.001
Spearman rho 
(rs)
rs= .548; N=42; 
p<.001
Descriptives indicate that the distribution of secretion rates, as hypothesised, was leptokurtic 
with relatively extreme outlying values. The question is whether kurtosis was sufficient for us 
to be confident of generalizing from this particular sample. Kolmogorov-Smirnoff one 
sample- tests were conducted to test null hypotheses of normal or uniform distribution of 
secretion rates. Table 1 shows these null hypotheses were rejected. Secretion rates are not 
distributed normally, nor do they involve a uniform series of roughly equal rise or fall 
amounts.
Temporal location descriptives are also presented. Table 1 shows that maximum rise 
intervals occurred on average at 25-mins post-awakening, and second highest rates 5-min 
earlier. Maximum fall was 5-mins later at 30-mins, and second highest a further 5-mins later. 
Finally, Table 1 shows maximum rate rise was correlated with maximum rate fall (rs = 0.55; N 
= 42; p<.001), suggesting a general potency in regard to the whole secretory response.
3.3. Study 1: Salience of individual secretion rate profiles
We hypothesised that maximum secretion rate before 30-min minus minimum secretion rate 
from 30-45 min would measure salience as a proxy PTA, which would correlate highly with 
PTA over the entire post-awakening hour. Using mixed regression modelling, polynomial 
trend analyses found a highly significant cubic function for secretion rates over the 45-min 
period (F=12.25; df =1, 350; p<.001), and a wave with a mean amplitude of (2.74). The 
degree of correlation between individual PTA estimates based on 0-45-mins versus 0-60-
mins was substantial and highly significant (rs = 0.80; N=42; p<.001).
In a second model, amplitude was added as a continuous covariate to the time covariate. 
The interaction term was significant (F=10.81; df =1, 321; p<.001). For visualization 
purposes only, this interactive effect obtained with continuous covariates (see Figure 2a) is 
illustrated by plotting model-predicted scores for the whole sample, together with groups of 
those above or below amplitude median. As can be seen, high and low amplitude groups 
show secretion rate curves with very different signal salience.
Figure 2. Interaction effect between peak to-trough amplitude (PTA) and cubic 
trend for secretion rate (2A). The same interaction is re-plotted for data re-cast 
as
the traditional growth curve in cortisol concentration (2B). 
The consequent impact of salience on the traditional CAR concentration curve is illustrated 
in Figure 2b. For the mean line, there was a clear sign of deceleration in mean concentration 
growth indicated by a significant quadratic trend (F= 12.11; df = 1,417; p<001) but no sign of 
fall. Estimates of amplitude interacted with quadratic trend (F= 26.46; df= 1,395; p<.001) 
such that the high salient group showed a clear move towards fall in the mean trend line, 
beginning after 35-mins. In contrast, the low salient group showed no sign of any significant 
deceleration after 30-mins.
3.4. Study 2: CAR salience and its diagnostic utility using a sparse sampling protocol
The remaining analyses re-examined data from a study where cortisol was measured over a 
45-mins period on two successive days in both summer and winter, in 26 cases of seasonal 
affective disorder (SAD) and 26 healthy controls.  Using the formula shown in Box 1 of the 
Methods, salience estimates were calculated from samples at awakening (s0), at 30-mins 
(s30) and at 45- mins (s45). The validity of the implicit assumption that peak and trough 
would be overwhelmingly located either side of 30-min, and that therefore this very simple 
formula would yield a useful approximation of PTA, was first  examined  in the 5-min data-
set. The correlation between our  simple salience measure and that based on rate difference 
between known (0-30-min) maximum and (30-45-min) minimum values was substantial (rs= 
0.80; N=42; p<.001), and almost identical to that reported above between 0-60 min and 0-
45min PTA estimates based on 5-min interval maxima and minima differences1.  
For the SAD study data, simple salience estimates for all four CARs were accordingly first 
averaged to express a trait-like variable. Binary logistic regression was used to assess how 
well average PTA scores discriminated between SAD cases and control cases, and to 
compare performance with a traditional AUCi measure of total cortisol secretion over 
awakening base. Table 2 presents a summary of results. 
Table 2. Prediction of Seasonal Affective Disorder (SAD) cases using CAR salience 
(PTA estimate), CAR magnitude (AUCi), and the two components of salience (0-30 and 
30-45 min post-awakening secretion rate
Wald Df Sig. Pseud
o R2
Single Models
CAR Salience                         
(PTA)
7.06 1 .008 .22
CAR Magnitude                      
(AUCi)
2.73 1 .098 .08
CAR mean secretion 
rate (0-30min)
4.55 1 .033 .13
CAR mean secretion 
rate (30-45min)
5.38 1 .020 .18
Multiple Models
Salience with 
Magnitude
4.91 1 .027 .22Salience
Magnitude
   0.01 1 .933
When CAR salience, operationalised as PTA estimate, was entered as the only predictor 
variable in the binary logistic regression, it proved significant, outperforming both AUCi and 
also each component of PTA, i.e. strength of positive secretion rate (rise) up to 30-mins, and 
strength of negative secretion rate (fall) from 30-45-mins. Wald tests were significant at a 
lower level for PTA components but AUCi failed to reach conventional significance (p<.098). 
Pseudo R2 values are also tabulated, indicating that discrimination between SAD cases and 
controls was considerably better for salience than AUCi and simple 0-30-mins rise. The 
multiple model indicates that when AUCi and salience are both simultaneously entered as 
1 Of interest to those with data from 0, 30, and 60 min samples, a simple 60-min salience measure 
highly correlated with this simple 45-min period estimate (rs= 0.88), but less strongly (rs= 0.65) with 
equivalent 0-60 min PTA estimate based on all 5-min intervals, although still highly significant. 
covariates, salience remains a significant predictor and AUCi makes no contribution, as is 
evident also from the model’s Pseudo R2 value (.22) which to two decimal places is the 
same as with salience alone. Although AUCi and salience had about a third of variance in 
common due to both expressing 0-30 min rise, this did not raise issues of multi-collinearity 
with tolerance / variance inflation being comfortably within acceptable ranges. Most 
importantly, therefore, the multiple model establishes that salience performs, not just better, 
but significantly better than AUCi.
Temporal stability over only two consecutive days was highly significant but predictably 
modest in strength and very similar for both PTA and AUCi (r= .51, p<.001; and .54, p<.001 
respectively). Both measures were considerably less stable across two seasons, though still 
significant (PTA rs= .34, p<.015; AUCi rs=.28, p<.048).
Finally, the possibly different functions reflected by salience and AUCi measures were 
illuminated to a degree in analyses which reversed independent and dependent variable. 
Multi-level modelling was used to examine seasonal differences in both salience and AUCi 
scores for SAD cases versus controls. Figures 3a shows that in summer AUCi scores of 
SAD and control cases were similar, but in winter SAD cases had significantly lower AUCi, 
as indicated by a significant interaction (F=7.38; df=1, 151; p<.007). This suggests that AUCi 
may be more responsive to within-subjects state changes in associated variables rather than 
being associated with trait-like between-subjects variables, including chronic conditions or 
clinical disorders
3A.                                                                                      3B
Figure 3.             Interaction effects (Season x Seasonal Affective Disorder [SAD] 
status) for traditional CAR magnitude measure (AUCi) Figure 2A, versus 
CAR salience (peak to-trough amplitude PTA estimate) Figure 2B. Error 
bars indicate standard errors.
The opposite is the case for salience. In Figure 3b we see that neither SAD nor control 
cases changed much with season. Instead, SAD cases exhibited less salient CARs than 
controls in both seasons, confirmed by a highly significant main effect (F=10.40; df=1, 50; 
p<.002).
Finally, subsidiary analyses were performed to check that reported effects for both PTA, as 
CAR salience, and AUCi, as CAR magnitude, were neither mediated nor modulated by the 
major demographics of age and sex. They were not.
4. Discussion
Analyses supported the view of the CAR as the first ultradian secretory episode of the day. 
At group level, aggregated data showed a smooth wave-like pattern of secretory activity with 
period length of almost exactly one hour, i.e. the predicted ultradian periodicity. Mean 
secretion rate accelerated from awakening to peak at 21-min, then decelerated to a trough of 
secretory activity at almost exactly the expected hour mark (59-mins). Finally, an upward 
swing offered a glimpse of renewed secretory activity, consistent with the commencement of 
a second ultradian episode. How much our findings meet ultradian expectation merits further 
discussion. Early studies,  following Veldhuis et al (1989),  measured plasma so Trifonova et 
al.’s (2013) rare saliva estimates are of particular importance: 61-min for period interval and 
29-min for half-life, with similar estimates for plasma. Our period interval match of 59-min 
was near perfect, and our half-life (40-min) a little longer. Tellingly, both studies confirm 
shorter estimates for both than earlier 24-h studies, suggesting that dominant or exclusive 
morning sampling may explain this. Trifonova et al. report poorer concordance for saliva and 
plasma peak detection in the afternoon, attributable to reduced peak amplitude. If we 
speculate that relative  individual differences in salience are conserved over the entire 
ultradian rhythm, even though  absolute amplitude diminishes dramatically after the CAR,  
then the CAR period itself becomes a promising one for ultradian research.  By dint of 
hosting secretory activity of such magnitude, it may constitute the easiest, and perhaps sole, 
opportunity in saliva, to examine, relatively free of noise, the more microscopic detail of 
pulsatile profiles, which may underpin salience and stability of ultradian signalling.  
As far as we know, this is the first study to explore individual differences in CAR profiles, 
while explicitly seeing them as segments of an ultradian as well as diurnal rhythm. If so, the 
novelty virtue of uniqueness has to be balanced by its limitation. It leaves much to replicate, 
although that could be said of CAR research in general. On the positive side, in the 5-min 
data-set, the accuracy of the sampling times relative to awakening, so crucial to the detailed 
examination of process and timing within the CAR, leads to confidence in the results 
reported. Also, given an established knowledge base on the periodicity of the ultradian 
rhythm and the pulsatile nature of cortisol secretion (Flynn et al., 2018; Trifonova et al.,2013; 
Lightman and Conway-Campbell, 2010; Veldhuis et al., 1989), it would frankly have been 
surprising if the evidence adduced here to show their foot-prints in the 5-min data had not 
been forthcoming. These foot-prints were the basis for subsequent analyses of individual 
peak to trough amplitude (PTA) estimates as potential indicators of CAR salience as a 
secretory signal. PTA at the individual level is not a parameter drawn from a smooth 
individual wave. Rather it contributes to the smooth aggregated wave by a spiky sequence of 
episodic bursts of secretory activity, typically patterned in terms of strength and location to 
show maximal activity before and minimal activity after 30 minutes post-awakening. 
The difference between these is what constitutes PTA at the individual level. Bursts will 
doubtless happen at other times, and indeed, in terms of the CAR as a circadian event, high 
magnitude responding may continue somewhat beyond the first hour post-awakening. 
However, given the functional importance of pulsatile cortisol secretion as a feedback signal 
in HPA ultradian regulation, we reasoned that PTA should reflect individual differences in the 
clarity and strength of this signal within an ultradian segment, a quality we have termed 
salience. Visualized, it is a shape which reflects the extent to which observed secretion rates 
over short intervals rise steeply to and fall steeply from a clear peak, with both rise and fall 
packaged into just a few 5-min intervals of extremely high and low rates. 
Evidence supported hypotheses.  Rates were predictably leptokurtically distributed and null 
hypotheses asserting either a normal distribution or uniform distribution were rejected. The 
majority of maximum bursts of secretion occurred shortly before 30-mins and minimum rates 
after 30-mins post-awakening. The latter were overwhelmingly negative rates, reflecting real 
falls in cortisol concentration. Maximum and minimal rates were significantly and positively 
correlated. This increased the potential salience of secretory signalling by increasing the 
probability that a steep and rapid rise to peak would be followed by a steep and rapid fall 
from peak. 
Proxy estimate of individual PTA using the point of minimal secretory activity from 30 to 45 
min correlated very highly with PTA calculated across the whole hour. Similar points can be 
made about the simplest of all the PTA measures (see Box 1), used in the final analyses to 
assess the utility of salience in relation to identifying a clinical disorder. The sparsest 
possible sampling protocol was deliberately selected, to reflect what is viable, cost-wise, in 
large sample CAR studies. As a result, there could be no firm location of individual peak 
from 0-30-mins or trough from 30-45-mins. However, clearly peak and trough still contributed 
to and were reflected in mean rates on either side of 30-mins respectively. Mean rates 
should yield more stable PTA estimates than those based on the difference between just two 
5-min sample intervals. Moreover, it was possible to use the 5-mins interval data-set as a 
testing ground. The simple salience measure calculated as difference between mean 0 to 
30min rate and mean 30 to 45 min rate correlated very highly with the PTA measure 
calculated as difference between identified 5-min peak and trough rates either side of 30-
mins. Caveats need stating. Composites, including AUCi, are poor substitutes for thorough 
analysis and purposive modelling of full data-sets. But if cortisol constitutes a single measure 
alongside other physiological and psychosocial variables, e.g. in an epidemiological study, 
all on-board measures will likely need to be economical, simple and reliable data summaries.  
If so, it is worth re-emphasizing what was stated in Methods. Salience raw scores, calculated 
as in Box 1, should be inspected for outliers and skewness, and adjusted before parametric 
analysis. For outliers, we advocate winsorising to +/- 3sd., a sensible compromise which 
sets limits on the distorting influence of outliers using parametric analyses, while recognizing 
that pulsatile secretory process is evidenced by outlier activity. Positive skewness of raw 
salience scores should also be expected and appropriately reduced. If parametric analysis of 
salience components is undertaken the same attention to distributional detail and adjustment 
would be required. However transformation to components is probably not necessary prior to 
construction of salience scores, since as reported in Methods near equivalent scales were 
created by both approaches.   
Traditionally CAR magnitude has been assessed using AUCi or equivalent measures. 
Associations with poorer well-being, health and more recently cognitive function have been 
reported (Desantis et al., 2015; Gardner et al., 2013; Kudielka and Kirschbaum, 2003; Law 
et al., 2015; O'Connor et al., 2009; Pruessner et al., 2007; Rimmele et al., 2010; Shi et al., 
2018; Violanti et al., 2017; Wahbeh et al., 2008; Wuest et al., 2000). However, interpreting 
the findings can be problematic since results are often inconsistent (Evans et al., 2007; 
Hodyl et al., 2016; Lovell et al., 2011; Steptoe et al., 2007; Steptoe et al., 2008; Thorn et al., 
2006). This makes it difficult to determine the functional significance of the CAR. New 
measures may be a useful additional indicator of dysfunction, in identifying significant 
departures from the shape of the CAR  
Put to the test, CAR salience, measured by a simple PTA estimate, performed significantly 
better than AUCi, the traditional CAR magnitude measure, in discriminating between control 
cases and cases with SAD. PTA also performed better than either its rise, or fall 
components. The PTA rise to 30-mins component is itself the simplest possible magnitude 
measure of the CAR and is much used when resources for more extensive sampling have 
been limited. It was a significant discriminator of SAD status in its own right, albeit with an 
effect size considerably lower than PTA. By contrast, AUCi over the 45-mins period eluded 
conventional 5% significance. This brings into stark relief the difference between a simple 
salience measure and AUCi, when the latter is calculated beyond 30-mins. AUCi adds all 
rise above awakening base, wherever it occurs. PTA is concerned with salience initially in 
the form of an ‘on’ signal, indicating that major increase in secretion rate is underway. Since 
this overwhelmingly occurs prior to 30-mins, any increases thereafter are not merely 
irrelevant, they serve to distort estimates of the peak component of PTA. The much used 
simple CAR rise to 30-mins tells half of the PTA story, and to that extent fully captures the 
‘on’ signal, but by definition it misses the subsequent ‘off’ signal that major increases in 
secretion are over for the current ultradian period. 
Salience and AUCi both showed moderately good temporal stability over consecutive days 
with AUCi higher by a very small margin. Over seasons, stability of both measures was 
much poorer, though still significant. Interestingly over the much longer time-period between 
seasons, it was salience which had the better stability, and by a bigger margin than was the 
case for AUCi over consecutive days. Clearly, such a trend would need considerably more 
repeated measures to establish statistical significance, but the pattern is noted here, 
because it hints at the possibility that salience, may be the better CAR measure for 
examining more trait-like individual differences while AUCi may be the better measure for 
examining shorter term state influences on the CAR , which of course is exactly what was 
reported in the final analyses. Decrease in AUCi, not salience, reflected the big within-
subjects seasonal changes in affective state, which define the SAD diagnosis (Thorn et al., 
2011). By contrast, salience, but not AUCi, reliably predicted the presence or absence of an 
enduring underlying disorder, regardless of the season in which it was measured. 
What more general lines of enquiry are suggested by these specific findings? What is the 
potential relevance to other clinical conditions, and, more widely, to the study of cortisol in 
relation to health, illness, and cognitive functioning? Certainly, we believe that salience as a 
construct merits further exploration, especially since it can be examined  alongside AUCi in 
exactly the same data-sets drawn from many of the same much-used sampling protocols. 
AUCi and salience both partly express the same cortisol rise from awakening to 30-min. So 
one implication of our findings must be that the  key difference between them lies in what 
happens to secretion rates after 30-min, and the answer is that salient profiles reduce 
secretory activity and non-salient ones continue or even increase  secretory activity between 
30 and 45min. This continued or increased secretory activity, as we saw in Table 2, was 
even on its own significantly predictive of SAD cases, and slightly more so than presence of 
smaller rise prior to 30-min, compared to controls. As far as we know and excepting this 
finding for SAD, we have no nuanced knowledge of how consistently late (post-30min) 
secretory activity at a trait-like level, sustaining continued elevation of the classic CAR 
concentration curve, may be related to other disorders. It is, of course, a component of 
overall AUCi measures, which stretch beyond 30-min, but we know of no analyses of AUCi 
which have sought to partition sub-areas under the curve and examine their specific role.  At 
the trait level for SAD, regardless of season, we have found low salience, with relatively 
smaller rise to 30-min and relatively greater rise from 30-45 min, to be a remarkably powerful 
predictor of cases. We do not know how salience will perform against AUCi in other 
conditions. For some disorders, like SAD, the consensus of studies of AUCi suggests the 
prevalence of lower magnitude CARs, but for others there is the suggestion of either 
exaggerated CARs or inconsistency and no consensus. Our findings might well inform such 
lack of consensus. A number of such studies will probably have used only 0-30 min rise 
(associated with high salience) as a CAR magnitude measure, and others will have used 
AUCi magnitude measures going beyond 30-min (with a portion therefore associated with 
low salience and low 0-30min rise). It is instructive to ask whether, given our present 
findings, the two types of magnitude measures might actually lean differentially to findings in 
opposing directions, and actually be generating inconsistency in the literature.  Perhaps this 
pinpoints the most general contribution that parallel investigation of salience as well as 
magnitude can make to CAR research. It will give us a richer and more diverse way of 
considering the CAR, including as an ultradian as well as circadian event. It invites us to 
think beyond an almost certainly over-simplified one-dimensional polarity view of clinical 
disorder as involving either abnormal hyper-responding or hypo-responding, with an implicit 
assumption that the whole CAR phenomenon is solely to be explained as a diurnal feature 
with simple magnitude of overall rise at its heart. A routine examination and reporting of 
salience as well as magnitude, as done here, in studies seeking to relate the CAR to health 
and illness domains, would, in our view, be a significant progressive innovation in the area of 
CAR research using composites. However we should be sanguine about degree of progress, 
given the limitations of research solely using simple composite measures . In our view, it 
needs to be emphasised that many more studies involving detailed mathematical modelling 
of secretory process, with high quality data, are needed, covering a period, certainly longer 
than one hour before we can begin truly to disentangle circadian and ultradian influences on 
the magnitude, shape, and duration of post-awakening cortisol elevation. Ultimately, we 
need to know much more about what drives the CAR as a complex secretory ‘phenomenon,’ 
not as a simple response, and certainly not a response defined by a single parameter. Only 
then will theory begin to inform hypothesising about the role of the CAR in clinical disorders 
and more besides.  
In conclusion, CAR salience, as a simple summary measure reflecting CAR shape, can be 
used alongside traditional indices of CAR magnitude. Although magnitude has been 
associated with poorer well-being, health and cognitive function, interpretation of the 
literature is difficult. Salience may be a useful additional indicator of dysfunction, in 
identifying significant departures from the normal shape of the CAR, which may help 
untangle functional significance of the CAR in health and disease. We end by re-
emphasizing a highly pragmatic point. Since both salience and magnitude can be analysed 
using exactly the same data from exactly the same sparse saliva sampling protocols, we 
believe further research, including re-analyses of existing data-sets, with good sample timing 
accuracy, is fully warranted, in order to illuminate associations between the CAR and other 
variables in clinically relevant domains.  Certainly, it is important to extend the focus of 
research to ask many more questions about individual differences in patterns of cortisol 
delivery in the CAR, not just how much is delivered.
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